S. Oro
Université Paris-Est Créteil(FR)Centre Hospitalier Universitaire Henri-Mondor(FR)Assistance Publique – Hôpitaux de Paris(FR)Assistance Publique – Hôpitaux de Paris(FR)Laboratoire National de Référence(MA)Hôpitaux Universitaires Henri-Mondor(FR)BioStrategies (United States)(US)Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers(FR)Lymphoma Study Association(FR)Université Gustave Eiffel(FR)
Publications by Year
Research Areas
Autoimmune Bullous Skin Diseases, Drug-Induced Adverse Reactions, Urticaria and Related Conditions, Cutaneous lymphoproliferative disorders research, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial(2017)587 cited
- → Risk Factors for Bullous Pemphigoid in the Elderly: A Prospective Case–Control Study(2010)296 cited
- → Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response(2013)238 cited
- → Systemic involvement of acute generalized exanthematous pustulosis: a retrospective study on 58 patients(2013)152 cited
- → Prognostic Factors of Paraneoplastic Pemphigus(2012)150 cited
- → Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis(2013)135 cited